Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Danaii, Shahla  [Clear All Filters]
Journal Article
Sheikhansari G, Pourmoghadam Z, Danaii S, Mehdizadeh A, Yousefi M. Etiology and management of recurrent implantation failure: A focus on intra-uterine PBMC-therapy for RIF. J Reprod Immunol. 2020;139:103121.
Danaii S, Ghorbani F, Ahmadi M, Abbaszadeh H, Koushaeian L, Soltani-Zangbar MSadegh, Mehdizadeh A, Hojjat-Farsangi M, Kafil HSamadi, Aghebati-Maleki L, et al. IL-10-producing B cells play important role in the pathogenesis of recurrent pregnancy loss. Int Immunopharmacol. 2020;87:106806.
Pishgahi A, Abolhasan R, Danaii S, Amanifar B, Soltani-Zangbar MSadegh, Zamani M, Kamrani A, Ghorbani F, Mehdizadeh A, Kafil HSamadi, et al. Immunological and oxidative stress biomarkers in Ankylosing Spondylitis patients with or without metabolic syndrome. Cytokine. 2020;128:155002.
Pourmoghadam Z, Soltani-Zangbar MSadegh, Sheikhansari G, Azizi R, Eghbal-Fard S, Mohammadi H, Siahmansouri H, Aghebati-Maleki L, Danaii S, Mehdizadeh A, et al. Intrauterine administration of autologous hCG- activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; A double-blind, randomized control trial study. J Reprod Immunol. 2020;142:103182.
Azizi R, Soltani-Zangbar MSadegh, Sheikhansari G, Pourmoghadam Z, Mehdizadeh A, Mahdipour M, Sandoghchian S, Danaii S, Koushaein L, Kafil HSamadi, et al. Metabolic syndrome mediates inflammatory and oxidative stress responses in patients with recurrent pregnancy loss. J Reprod Immunol. 2019;133:18-26.
Ahmadi M, Ghaebi M, Abdolmohammadi-Vahid S, Abbaspour-Aghdam S, Hamdi K, Abdollahi-Fard S, Danaii S, Mosapour P, Koushaeian L, Dolati S, et al. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss. J Cell Physiol. 2018.
Sheikhansari G, Soltani-Zangbar MSadegh, Pourmoghadam Z, Kamrani A, Azizi R, Aghebati-Maleki L, Danaii S, Koushaeian L, Hojat-Farsangi M, Yousefi M. Oxidative stress, inflammatory settings, and microRNA regulation in the recurrent implantation failure patients with metabolic syndrome. Am J Reprod Immunol. 2019:e13170.
Koushaeian L, Ghorbani F, Ahmadi M, Eghbal-Fard S, Zamani M, Danaii S, Yousefi B, Jadidi-Niaragh F, Hamdi K, Yousefi M. The role of IL-10-producing B cells in Repeated Implantation Failure patients with cellular immune abnormalities. Immunol Lett. 2019.
Ahmadi M, Abdolmohamadi-Vahid S, Ghaebi M, Dolati S, Abbaspour-Aghdam S, Danaii S, Berjis K, Madadi-Javid R, Nouri Z, Siahmansouri H, et al. Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial. Int Immunopharmacol. 2019;74:105730.